Drug intelligence / Profile preview

human placenta extract

Development stage
Unknown
Lead developer
Cellav Health and Aesthetics
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Intramuscular, Subcutaneous
01

Overview

Placento+ is a brand of human placenta extract (HPE) primarily utilized in aesthetic medicine and regenerative therapy. Derived from human placental tissue, it consists of a complex mixture of bioactive components, including growth factors such as hepatocyte growth factor (HGF), epidermal growth factor (EGF), and fibroblast growth factor (FGF), as well as amino acids, vitamins, and minerals. The product is typically administered via intramuscular or subcutaneous injection to promote skin rejuvenation, wound healing, and anti-aging effects. Its mechanism of action involves the stimulation of fibroblast proliferation, enhancement of collagen and elastin synthesis, and modulation of inflammatory responses. While human placenta extracts are regulated as pharmaceutical biologics in certain jurisdictions (e.g., Japan and India) for conditions like hepatic cirrhosis and menopausal symptoms, Placento+ is frequently marketed for cosmetic improvements and is registered as a pharmaceutical product in several Southeast Asian markets.

Brand names
Placento+PlacentoPlacentrexLaennecMelsmon
Other names
HPEhuman placenta extract
02

Targets

MET (Mesenchymal-epithelial transition factor receptor)EGFR (Epidermal growth factor receptor)VEGFR (VEGFR family)FGFR (FGFR family)

Beyond the preview

Go deeper on human placenta extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human placenta extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call